Description

Cartalax 20 mg

Product Description

Cartalax, also identified as Ala-Glu-Asp, AED, or H-Ala-Glu-Asp-OH, is a synthetic tripeptide composed of L-alanine, L-glutamic acid, and L-aspartic acid.

Cartalax 20 mg is supplied as a laboratory research reagent for controlled analytical, biochemical, and molecular research. Appropriate research applications may include peptide characterization, analytical-method development, short-peptide interaction studies, gene-expression models, and extracellular-matrix research conducted in lawful non-clinical laboratory settings.

Research Specifications

Product: Cartalax
Sequence: Ala–Glu–Asp
Content: 20 mg
CAS Number: 85806-95-7
Molecular Formula: C₁₂H₁₉N₃O₈
Molecular Weight: 333.29 g/mol
Format: Lyophilized research material

Research Use Notice

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE. NOT FOR USE IN DIAGNOSTIC PROCEDURES. NOT INTENDED FOR USE AS A FOOD, DRUG, COSMETIC, DIETARY SUPPLEMENT, MEDICAL DEVICE, OR HOUSEHOLD PRODUCT.

This material is intended exclusively for use by qualified laboratory personnel. It is not intended for clinical administration, personal experimentation, compounding, consumption, or application to humans or animals.